{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:07:45Z","timestamp":1778821665988,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 DK134752"],"award-info":[{"award-number":["K23 DK134752"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cgh.2024.01.049","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T06:38:11Z","timestamp":1708065491000},"page":"263-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Heartburn Relief Is the Major Unmet Need for Drug Development in Gastroesophageal Reflux Disease: Threshold Value Analysis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3611-8628","authenticated-orcid":false,"given":"Eric D.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Curley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai-Kit","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.01.049_bib1","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/j.gastro.2019.12.014","article-title":"Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms","volume":"158","author":"Delshad","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.049_bib2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1053\/j.gastro.2021.10.017","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021","volume":"162","author":"Peery","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.049_bib3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.14309\/ajg.0000000000000734","article-title":"ACG clinical guidelines: clinical use of esophageal physiologic testing","volume":"115","author":"Gyawali","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.049_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.049_bib5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.14309\/ajg.0000000000001728","article-title":"2021 National Survey on Prior Authorization Burden and its impact on gastroenterology practice","volume":"117","author":"Shah","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.049_bib6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1442-2050.2011.01313.x","article-title":"Variation of health-care resource utilization according to GERD-associated complications","volume":"25","author":"Gerson","year":"2012","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.cgh.2024.01.049_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1524-4733.2008.00399.x","article-title":"The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease","volume":"12","author":"Gosselin","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.cgh.2024.01.049_bib8","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1007\/s10620-020-06806-1","article-title":"Price is right: exploring prescription drug coverage barriers for irritable bowel syndrome using threshold pricing analysis","volume":"66","author":"Shah","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2024.01.049_bib9","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.cgh.2019.02.039","article-title":"Value-based pricing for rifaximin increases access of patients with irritable bowel syndrome with diarrhea to therapy","volume":"17","author":"Shah","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.01.049_bib10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.14309\/ajg.0000000000000989","article-title":"Contrasting clinician and insurer perspectives to managing irritable bowel syndrome: multilevel modeling analysis","volume":"116","author":"Shah","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.049_bib11","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.14309\/ajg.0000000000001403","article-title":"Evaluating the impact of cost on the treatment algorithm for chronic idiopathic constipation: cost-effectiveness analysis","volume":"116","author":"Shah","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.049_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.gastro.2022.09.041","article-title":"Vonoprazan versus lansoprazole for healing and maintenance of healing of erosive esophagitis: a randomized trial","volume":"164","author":"Laine","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.049_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2024.01.049_bib14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1572-0241.2005.40588.x","article-title":"Patient-derived health state utilities for gastroesophageal reflux disease","volume":"100","author":"Gerson","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.049_bib15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1811424","article-title":"Randomized trial of medical versus surgical treatment for refractory heartburn","volume":"381","author":"Spechler","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2024.01.049_bib16","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-2036.2008.03671.x","article-title":"Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort: relationship between GERD symptoms and burden of illness","volume":"27","author":"Wahlqvist","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.01.049_bib17","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2022.19566","article-title":"Trends in reported health care affordability for men and women with employer-sponsored health insurance coverage in the US, 2000 to 2020","volume":"328","author":"Gupta","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2024.01.049_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/jama.2020.0070","article-title":"Changing the game of prior authorization: the patient perspective","volume":"323","author":"Gaines","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2024.01.049_bib19","article-title":"Optimizing the management algorithm for heartburn in general gastroenterology: cost-effectiveness and cost-minimization analysis","author":"Shah","year":"2023","journal-title":"Clin Gastroenterol Hepatol September"},{"key":"10.1016\/j.cgh.2024.01.049_bib20","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.cgh.2020.03.057","article-title":"Untangling nonerosive reflux disease from functional heartburn","volume":"19","author":"Patel","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.01.049_bib21","first-page":"3","article-title":"Mean, median, and skew: correcting a textbook rule","volume":"13","author":"von Hippel","year":"2005","journal-title":"J\u00a0Stat Educ"},{"key":"10.1016\/j.cgh.2024.01.049_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14469","article-title":"Comparison of acid-lowering drugs for endoscopy negative reflux disease: systematic review and network meta-analysis","volume":"35","author":"Barberio","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2024.01.049_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cgh.2020.07.057","article-title":"Dissecting drug pricing in gastroenterology and hepatology","volume":"19","author":"Thompson","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.01.049_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/MCG.0000000000001707","article-title":"Network meta-analysis comparing vonoprazan and proton pump inhibitors for heartburn symptoms in erosive esophagitis","volume":"56","author":"Oshima","year":"2022","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.049_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2036.2007.03428.x","article-title":"Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States: cost of illness of GERD to the employer","volume":"26","author":"Brook","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.01.049_bib26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1365-2036.2003.01588.x","article-title":"The burden of illness of gastro-oesophageal reflux disease: impact on work productivity: the burden of illness of GERD","volume":"17","author":"Dean","year":"2003","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524002027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524002027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:13:55Z","timestamp":1778818435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524002027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1542356524002027"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.01.049","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heartburn Relief Is the Major Unmet Need for Drug Development in Gastroesophageal Reflux Disease: Threshold Value Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.01.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the AGA Institute","name":"copyright","label":"Copyright"}]}}